Published in Transl Perioper Pain Med on August 18, 2016
Incidence and outcomes of acute lung injury. N Engl J Med (2005) 21.56
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity (2005) 14.95
Evidence-based health policy--lessons from the Global Burden of Disease Study. Science (1996) 13.50
Acute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet (2007) 6.07
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood (2011) 5.61
Helical assembly in the MyD88-IRAK4-IRAK2 complex in TLR/IL-1R signalling. Nature (2010) 4.61
Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases. Immunity (2009) 4.49
The interleukin-1 family: back to the future. Immunity (2013) 3.90
Distinct molecular mechanism for initiating TRAF6 signalling. Nature (2002) 3.82
The IL-1-like cytokine IL-33 is inactivated after maturation by caspase-1. Proc Natl Acad Sci U S A (2009) 3.39
IL-33-dependent type 2 inflammation during rhinovirus-induced asthma exacerbations in vivo. Am J Respir Crit Care Med (2014) 3.32
Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem (2007) 3.11
Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. Am J Respir Crit Care Med (2003) 2.44
Interleukin-33 - cytokine of dual function or novel alarmin? Trends Immunol (2009) 2.40
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A (2007) 2.27
Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity (2015) 2.12
A putative protein of a growth specific cDNA from BALB/c-3T3 cells is highly similar to the extracellular portion of mouse interleukin 1 receptor. FEBS Lett (1989) 2.07
Role of IL-33 in inflammation and disease. J Inflamm (Lond) (2011) 2.06
Interleukin-33 is biologically active independently of caspase-1 cleavage. J Biol Chem (2009) 2.00
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G. Proc Natl Acad Sci U S A (2012) 1.99
Chitin activates parallel immune modules that direct distinct inflammatory responses via innate lymphoid type 2 and γδ T cells. Immunity (2014) 1.87
Orchestrating house dust mite-associated allergy in the lung. Trends Immunol (2011) 1.86
Endogenous IL-33 is highly expressed in mouse epithelial barrier tissues, lymphoid organs, brain, embryos, and inflamed tissues: in situ analysis using a novel Il-33-LacZ gene trap reporter strain. J Immunol (2012) 1.85
An oligomeric signaling platform formed by the Toll-like receptor signal transducers MyD88 and IRAK-4. J Biol Chem (2009) 1.85
Serum- and oncoprotein-mediated induction of a gene with sequence similarity to the gene encoding carcinoembryonic antigen. Proc Natl Acad Sci U S A (1989) 1.73
IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol (2014) 1.71
The dual function cytokine IL-33 interacts with the transcription factor NF-κB to dampen NF-κB-stimulated gene transcription. J Immunol (2011) 1.59
IL-33 mediates inflammatory responses in human lung tissue cells. J Immunol (2010) 1.55
IL-33 family members and asthma - bridging innate and adaptive immune responses. Curr Opin Immunol (2010) 1.41
Ventilatory management of acute lung injury and acute respiratory distress syndrome. JAMA (2005) 1.39
Identification of genes differentially expressed in canine vasospastic cerebral arteries after subarachnoid hemorrhage. J Cereb Blood Flow Metab (1999) 1.35
The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33. Cytokine (2008) 1.32
IL-33 raises alarm. Immunity (2009) 1.24
Interleukin-33 and the function of innate lymphoid cells. Trends Immunol (2012) 1.20
Tissue distribution and subcellular localization of a variant form of the human ST2 gene product, ST2V. Biochem Biophys Res Commun (2001) 1.20
IL-33 promotes ST2-dependent lung fibrosis by the induction of alternatively activated macrophages and innate lymphoid cells in mice. J Allergy Clin Immunol (2014) 1.19
ST2/T1 protein functionally binds to two secreted proteins from Balb/c 3T3 and human umbilical vein endothelial cells but does not bind interleukin 1. J Biol Chem (1995) 1.16
The TLR and IL-1 signalling network at a glance. J Cell Sci (2014) 1.01
An Interleukin-33-Mast Cell-Interleukin-2 Axis Suppresses Papain-Induced Allergic Inflammation by Promoting Regulatory T Cell Numbers. Immunity (2015) 0.98
Interleukin-33 potentiates bleomycin-induced lung injury. Am J Respir Cell Mol Biol (2013) 0.98
Human mesenchymal stem cells overexpressing the IL-33 antagonist soluble IL-1 receptor-like-1 attenuate endotoxin-induced acute lung injury. Am J Respir Cell Mol Biol (2013) 0.92
Group 2 innate lymphoid cells utilize the IRF4-IL-9 module to coordinate epithelial cell maintenance of lung homeostasis. Mucosal Immunol (2015) 0.92
Soluble ST2: a new and promising activity marker in ulcerative colitis. World J Gastroenterol (2011) 0.91
Oxidation of the alarmin IL-33 regulates ST2-dependent inflammation. Nat Commun (2015) 0.90
Pediatric severe asthma with fungal sensitization is mediated by steroid-resistant IL-33. J Allergy Clin Immunol (2015) 0.88
Signaling through FcRγ-associated receptors on dendritic cells drives IL-33-dependent TH2-type responses. J Allergy Clin Immunol (2014) 0.87
IL-33 drives airway hyper-responsiveness through IL-13-mediated mast cell: airway smooth muscle crosstalk. Allergy (2015) 0.87
Pulmonary receptor for advanced glycation end-products promotes asthma pathogenesis through IL-33 and accumulation of group 2 innate lymphoid cells. J Allergy Clin Immunol (2015) 0.85
Virus-like particles presenting interleukin-33 molecules: immunization characteristics and potentials of blockingIL-33/ST2 pathway in allergic airway inflammation. Hum Vaccin Immunother (2014) 0.85
Cytokine profile determined by data-mining analysis set into clusters of non-small-cell lung cancer patients according to prognosis. Ann Oncol (2014) 0.83
Increased IL-33 expression in chronic obstructive pulmonary disease. Am J Physiol Lung Cell Mol Physiol (2015) 0.81
Novel insights into miRNA in lung and heart inflammatory diseases. Mediators Inflamm (2014) 0.81
AMCase is a crucial regulator of type 2 immune responses to inhaled house dust mites. Proc Natl Acad Sci U S A (2015) 0.81
Caspase-1 activation by NLRP3 inflammasome dampens IL-33-dependent house dust mite-induced allergic lung inflammation. J Mol Cell Biol (2015) 0.81
A potential role for interleukin-33 and γ-epithelium sodium channel in the pathogenesis of human malaria associated lung injury. Malar J (2015) 0.80
Membrane translocation of IL-33 receptor in ventilator induced lung injury. PLoS One (2015) 0.80
IL-33 promotes the induction of immunoglobulin production after inhalation of house dust mite extract in mice. Allergy (2015) 0.79
IL-33 Receptor (ST2) Signalling is Important for Regulation of Th2-Mediated Airway Inflammation in a Murine Model of Acute Respiratory Syncytial Virus Infection. Scand J Immunol (2015) 0.79
New dog and new tricks: evolving roles for IL-33 in type 2 immunity. J Leukoc Biol (2015) 0.79
Granulomas are a source of interleukin-33 expression in pulmonary and extrapulmonary sarcoidosis. Hum Pathol (2014) 0.79
Contrasting roles for the receptor for advanced glycation end-products on structural cells in allergic airway inflammation vs. airway hyperresponsiveness. Am J Physiol Lung Cell Mol Physiol (2015) 0.79
Rebamipide suppresses mite-induced asthmatic responses in NC/Nga mice. Am J Physiol Lung Cell Mol Physiol (2015) 0.78
ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice. Eur J Immunol (2015) 0.78
Clinical relevance of sST2 in cardiac diseases. Clin Chem Lab Med (2016) 0.78
Circulating IL-33 level is associated with the progression of lung cancer. Lung Cancer (2015) 0.78
Distinct sustained structural and functional effects of interleukin-33 and interleukin-25 on the airways in a murine asthma surrogate. Immunology (2015) 0.77
Cigarette smoke resets the Alarmin IL-33 in COPD. Immunity (2015) 0.77
Vitamin D enhances production of soluble ST2, inhibiting the action of IL-33. J Allergy Clin Immunol (2014) 0.77
Cigarette smoke alters IL-33 expression and release in airway epithelial cells. Biochim Biophys Acta (2014) 0.77
Inhaled house dust programs pulmonary dendritic cells to promote type 2 T-cell responses by an indirect mechanism. Am J Physiol Lung Cell Mol Physiol (2015) 0.77
Interleukin-33 as a New Marker of Pulmonary Sarcoidosis. Adv Exp Med Biol (2015) 0.76
Inflammation-induced expression of the alarmin interleukin 33 can be suppressed by galacto-oligosaccharides. Int Arch Allergy Immunol (2015) 0.76
Pathogenesis and prevention strategies of severe asthma exacerbations in children. Curr Opin Pulm Med (2016) 0.76
Vaccination against IL-33 Inhibits Airway Hyperresponsiveness and Inflammation in a House Dust Mite Model of Asthma. PLoS One (2015) 0.76
Rhinovirus infection interferes with induction of tolerance to aeroantigens through OX40 ligand, thymic stromal lymphopoietin, and IL-33. J Allergy Clin Immunol (2015) 0.76